0001209191-22-009337.txt : 20220214 0001209191-22-009337.hdr.sgml : 20220214 20220214164729 ACCESSION NUMBER: 0001209191-22-009337 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220211 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coleman Glenn CENTRAL INDEX KEY: 0001434369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 22633699 MAIL ADDRESS: STREET 1: C/O CURTISS-WRIGHT CORPORATION STREET 2: 4 BECKER FARM ROAD CITY: ROSELAND STATE: NJ ZIP: 07068 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 1100 CAMPUS ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-11 0 0000917520 INTEGRA LIFESCIENCES HOLDINGS CORP IART 0001434369 Coleman Glenn 1100 CAMPUS ROAD PRINCETON NJ 08540 0 1 0 0 Executive Vice President & COO Common Stock 2022-02-11 4 A 0 5892 0.00 A 34046 D Common Stock 2022-02-11 4 A 0 10837 0.00 A 44883 D Common Stock 2022-02-11 4 A 0 12576 0.00 A 57459 D On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date. Includes 373 shares acquired under the Integra Employee Stock Purchase Plan since the date of the reporting person's most recent filing on Form 4. On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date. On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date. /s/ Eric Schwartz; Attorney-in-Fact 2022-02-14